These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26205293)

  • 1. The soluble transcobalamin receptor (sCD320) is present in cerebrospinal fluid and correlates to dementia-related biomarkers tau proteins and amyloid-beta.
    Abuyaman O; Nexo E
    Scand J Clin Lab Invest; 2015 Oct; 75(6):514-8. PubMed ID: 26205293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First trimester serum levels of the soluble transcobalamin receptor, holo-transcobalamin, and total transcobalamin in relation to preeclampsia risk.
    Abuyaman O; Torring N; Obeid R; Nexo E
    Scand J Clin Lab Invest; 2016 Dec; 76(8):641-644. PubMed ID: 27700208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The soluble transcobalamin receptor (sCD320) in relation to Alzheimer's disease and cognitive scores.
    Abuyaman O; Combrinck M; Smith AD; Nexo E
    Scand J Clin Lab Invest; 2017 Sep; 77(5):332-337. PubMed ID: 28486088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The soluble receptor for vitamin B12 uptake (sCD320) increases during pregnancy and occurs in higher concentration in urine than in serum.
    Abuyaman O; Andreasen BH; Kronborg C; Vittinghus E; Nexo E
    PLoS One; 2013; 8(8):e73110. PubMed ID: 24015289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
    Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.
    Fagan AM; Roe CM; Xiong C; Mintun MA; Morris JC; Holtzman DM
    Arch Neurol; 2007 Mar; 64(3):343-9. PubMed ID: 17210801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three family members with elevated plasma cobalamin, transcobalamin and soluble transcobalamin receptor (sCD320).
    Hoffmann-Lücke E; Arendt JF; Nissen PH; Mikkelsen G; Aasly JO; Nexo E
    Clin Chem Lab Med; 2013 Mar; 51(3):677-82. PubMed ID: 23183759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort.
    Schoonenboom NS; Reesink FE; Verwey NA; Kester MI; Teunissen CE; van de Ven PM; Pijnenburg YA; Blankenstein MA; Rozemuller AJ; Scheltens P; van der Flier WM
    Neurology; 2012 Jan; 78(1):47-54. PubMed ID: 22170879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging.
    Sjögren M; Minthon L; Davidsson P; Granérus A-K ; Clarberg A; Vanderstichele H; Vanmechelen E; Wallin A; Blennow K
    J Neural Transm (Vienna); 2000; 107(5):563-79. PubMed ID: 11072752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
    Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T
    Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shedded cell membrane proteins in plasma: Pure waste, or informative biomarkers of pathophysiological processes?
    Breimer LH; Nilsson TK
    Scand J Clin Lab Invest; 2015 Oct; 75(6):441-3. PubMed ID: 26205294
    [No Abstract]   [Full Text] [Related]  

  • 12. Neprilysin-like activity correlates with CSF-Tau and phospho-tau in patients with Alzheimer's disease.
    Sorensen KC; Simonsen AH; Holmetoft UB; Hasselbalch SG; Heegaard NH
    J Alzheimers Dis; 2013; 37(2):379-87. PubMed ID: 23948879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.
    Kang JH; Vanderstichele H; Trojanowski JQ; Shaw LM
    Methods; 2012 Apr; 56(4):484-93. PubMed ID: 22503777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics.
    Lelental N; Brandner S; Kofanova O; Blennow K; Zetterberg H; Andreasson U; Engelborghs S; Mroczko B; Gabryelewicz T; Teunissen C; Mollenhauer B; Parnetti L; Chiasserini D; Molinuevo JL; Perret-Liaudet A; Verbeek MM; Andreasen N; Brosseron F; Bahl JM; Herukka SK; Hausner L; Frölich L; Labonte A; Poirier J; Miller AM; Zilka N; Kovacech B; Urbani A; Suardi S; Oliveira C; Baldeiras I; Dubois B; Rot U; Lehmann S; Skinningsrud A; Betsou F; Wiltfang J; Gkatzima O; Winblad B; Buchfelder M; Kornhuber J; Lewczuk P
    J Alzheimers Dis; 2016 Mar; 52(1):51-64. PubMed ID: 26967210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia.
    Skillbäck T; Farahmand BY; Rosén C; Mattsson N; Nägga K; Kilander L; Religa D; Wimo A; Winblad B; Schott JM; Blennow K; Eriksdotter M; Zetterberg H
    Brain; 2015 Sep; 138(Pt 9):2716-31. PubMed ID: 26133663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate and methylation status in relation to phosphorylated tau protein(181P) and beta-amyloid(1-42) in cerebrospinal fluid.
    Obeid R; Kasoha M; Knapp JP; Kostopoulos P; Becker G; Fassbender K; Herrmann W
    Clin Chem; 2007 Jun; 53(6):1129-36. PubMed ID: 17384003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two analytical platforms for the clinical qualification of Alzheimer's disease biomarkers in pathologically-confirmed dementia.
    Le Bastard N; Coart E; Vanderstichele H; Vanmechelen E; Martin JJ; Engelborghs S
    J Alzheimers Dis; 2013; 33(1):117-31. PubMed ID: 22936010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-sectional and longitudinal associations of motor fluctuations and non-motor predominance with cerebrospinal τ and Aβ as well as dementia-risk in Parkinson's disease.
    Modreanu R; Cerquera SC; Martí MJ; Ríos J; Sánchez-Gómez A; Cámara A; Fernández M; Compta Y
    J Neurol Sci; 2017 Feb; 373():223-229. PubMed ID: 28131192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic normal-pressure hydrocephalus, cerebrospinal fluid biomarkers, and the cerebrospinal fluid tap test.
    Kang K; Ko PW; Jin M; Suk K; Lee HW
    J Clin Neurosci; 2014 Aug; 21(8):1398-403. PubMed ID: 24836892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How many biomarkers to discriminate neurodegenerative dementia?
    Sancesario GM; Bernardini S
    Crit Rev Clin Lab Sci; 2015; 52(6):314-26. PubMed ID: 26292074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.